80_FR_46460 80 FR 46311 - National Institute of Neurological Disorders and Stroke: Notice of Closed Meetings

80 FR 46311 - National Institute of Neurological Disorders and Stroke: Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 149 (August 4, 2015)

Page Range46311-46311
FR Document2015-19032

Federal Register, Volume 80 Issue 149 (Tuesday, August 4, 2015)
[Federal Register Volume 80, Number 149 (Tuesday, August 4, 2015)]
[Notices]
[Page 46311]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-19032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke: Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Review of U24 Applications for 
Parkinson's Disease Repositories.
    Date: August 11, 2015.
    Time: 9:00 a.m. to 1:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Joel A. Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3205, MSC 9529, Bethesda, MD 20892-9529, 301-435-9223, 
[email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Review of U01 Applications for 
Parkinson's Disease Biomarker Program.
    Date: August 12, 2015.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Joel A. Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3205, MSC 9529, Bethesda, MD 20892-9529, 301-435-9223.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: July 29, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-19032 Filed 8-3-15; 8:45 am]
BILLING CODE 4140-01-P



                                                                            Federal Register / Vol. 80, No. 149 / Tuesday, August 4, 2015 / Notices                                                 46311

                                              Development Stage                                          • To study the patho/physiology of                 Emphasis Panel; Review of U24 Applications
                                                                                                      tissues that express WISP1, including                 for Parkinson’s Disease Repositories.
                                              • In vitro data available                                                                                       Date: August 11, 2015.
                                              • In vivo data available (animal)                       cartilage during osteoarthritis, healing
                                                                                                                                                              Time: 9:00 a.m. to 1:00 p.m.
                                                                                                      skin, and other soft tissues including
                                                Inventors: John Chiorini and Giovanni                                                                         Agenda: To review and evaluate grant
                                                                                                      lung, pancreas, and heart.                            applications.
                                              Pasquale (NIDCR).
                                                Publication: Schmidt M, et al.                           Development Stage: In vivo data                      Place: National Institutes of Health,
                                              Identification and characterization of                  available (animal).                                   Neuroscience Center, 6001 Executive
                                              novel adeno-associated virus isolates in                   Inventors: Marian F. Young, Mitsuaki               Boulevard, Rockville, MD 20852, (Telephone
                                                                                                      Ono, Azusa Maeda (all of NIDCR).                      Conference Call).
                                              ATCC virus stocks. J Virol. 2006 May;                                                                           Contact Person: Joel A. Saydoff, Ph.D.,
                                              80 (10): 5082–5098. [PMID 16641301]                        Publication: Maeda A, et al. WNT1-
                                                                                                                                                            Scientific Review Officer, Scientific Review
                                                Intellectual Property: HHS Reference                  induced secreted protein-1 (WISP1), a                 Branch, Division of Extramural Research,
                                              No. E–175–2015/0—US Application No.                     novel regulator of bone turnover and                  NINDS/NIH/DHHS/Neuroscience Center,
                                              62/160,552 filed May 12, 2015.                          Wnt signaling. J Bio Chem. 2015 May                   6001 Executive Boulevard, Suite 3205, MSC
                                                                                                      29;290(22):14004–18. [PMID 25864198]                  9529, Bethesda, MD 20892–9529, 301–435–
                                              Related Technologies                                       Intellectual Property: HHS Reference               9223, joel.saydoff@nih.gov.
                                                • E–097–2015: US 62/143,524.                          No. E–234–2015/0—Research Tool.                         Name of Committee: National Institute of
                                                • E–736–2013: PCT/US14/59825.                         Patent protection is not being pursued                Neurological Disorders and Stroke Special
                                                • E–142–2011 family: PCT/US12/                        for this technology.                                  Emphasis Panel; Review of U01 Applications
                                              34268, CA, EP and US.                                      Licensing Contact: Sally Hu, Ph.D.,                for Parkinson’s Disease Biomarker Program.
                                                • E–087–2011 family: PCT/US12/                        M.B.A.; 301–435–5606; hus@
                                                                                                                                                              Date: August 12, 2015.
                                              33556, EP and US.                                                                                               Time: 8:00 a.m. to 12:00 p.m.
                                                                                                      mail.nih.gov                                            Agenda: To review and evaluate grant
                                                • E–232–2011: US 14/428,929.                             Collaborative Research Opportunity:                applications.
                                                • E–194–2010: US 8,808,684.                           The National Institute of Dental and                    Place: National Institutes of Health,
                                                • E–179–2005: US 8,283,151.                           Craniofacial Research is seeking                      Neuroscience Center, 6001 Executive
                                                • E–227–2004: US 7,407,801.                           statements of capability or interest from             Boulevard, Rockville, MD 20852, (Telephone
                                                • E–329–2003 family: US 8,137,960,                                                                          Conference Call).
                                                                                                      parties interested in collaborative
                                              US 8,685,722.                                                                                                   Contact Person: Joel A. Saydoff, Ph.D.,
                                                                                                      research to further develop, evaluate or
                                                • E–105–2003: US 8,927,269.                                                                                 Scientific Review Officer, Scientific Review
                                                • E–308–2001: US 7,419,817.                           commercialize WNT1-Induced Secreted                   Branch, Division of Extramural Research,
                                                • E–071–2000: US 6,468,524.                           Protein-1 Knockout Mouse Model. For                   NINDS/NIH/DHHS/Neuroscience Center,
                                                • E–127–1998 family: US 6,984,517,                    collaboration opportunities, please                   6001 Executive Boulevard, Suite 3205, MSC
                                              AU, CA, EP, and JP.                                     contact David Bradley, Ph.D. at                       9529, Bethesda, MD 20892–9529, 301–435–
                                                Licensing Contact: Sally Hu, Ph.D.,                   bradleyda@nidcr.nih.gov.                              9223.
                                              M.B.A.; 301–435–5606; hus@                                Dated: July 30, 2015.                               (Catalogue of Federal Domestic Assistance
                                              mail.nih.gov.                                                                                                 Program Nos. 93.853, Clinical Research
                                                                                                      Richard U. Rodriguez,
                                                                                                                                                            Related to Neurological Disorders; 93.854,
                                                Collaborative Research Opportunity:                   Acting Director, Office of Technology                 Biological Basis Research in the
                                              The National Institute of Dental and                    Transfer, National Institutes of Health.              Neurosciences, National Institutes of Health,
                                              Craniofacial Research is seeking                        [FR Doc. 2015–19082 Filed 8–3–15; 8:45 am]            HHS)
                                              statements of capability or interest from               BILLING CODE 4140–01–P                                  Dated: July 29, 2015.
                                              parties interested in collaborative
                                              research to further develop, evaluate or                                                                      Carolyn Baum,
                                              commercialize AAV44–9 vector for gene                                                                         Program Analyst, Office of Federal Advisory
                                                                                                      DEPARTMENT OF HEALTH AND                              Committee Policy.
                                              therapy. For collaboration                              HUMAN SERVICES
                                              opportunities, please contact David                                                                           [FR Doc. 2015–19032 Filed 8–3–15; 8:45 am]
                                              Bradley, Ph.D. at bradleyda@                            National Institutes of Health                         BILLING CODE 4140–01–P
                                              nidcr.nih.gov.
                                                                                                      National Institute of Neurological
                                              WNT1-Induced Secreted Protein-1                         Disorders and Stroke: Notice of Closed                DEPARTMENT OF HEALTH AND
                                              Knockout Mouse Model                                    Meetings                                              HUMAN SERVICES
                                                 Description of Technology: WNT1-
                                              induced secreted protein-1 (WISP1) is                     Pursuant to section 10(d) of the                    National Institutes of Health
                                              expressed at high levels in osteoblasts                 Federal Advisory Committee Act, as
                                                                                                      amended (5 U.S.C. App.), notice is                    Center for Scientific Review: Notice of
                                              and their precursors. WIPS1 plays an                                                                          Closed Meeting
                                              important role in various aspects of                    hereby given of the following meetings.
                                              bone formation. Scientists at the NIH                     The meetings will be closed to the                    Pursuant to section 10(d) of the
                                              generated Wisp1-deficient (Wisp1-/-)                    public in accordance with the                         Federal Advisory Committee Act, as
                                              mice. Deletion of Wisp1 resulted in a                   provisions set forth in sections                      amended (5 U.S.C. App.), notice is
                                              decrease in bone mineral density, total                 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,            hereby given of the following meeting.
                                              bone volume, bone thickness, and                        as amended. The grant applications and                  The meeting will be closed to the
                                              biomechanical strength. Wisp1                           the discussions could disclose                        public in accordance with the
                                              knockout mouse model can be used to                     confidential trade secrets or commercial              provisions set forth in sections
                                              study the molecular mechanisms of                       property such as patentable material,                 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                      and personal information concerning
tkelley on DSK3SPTVN1PROD with NOTICES




                                              bone turnover and patho/physiology of                                                                         as amended. The grant applications and
                                              tissues that express WISP1.                             individuals associated with the grant                 the discussions could disclose
                                                                                                      applications, the disclosure of which                 confidential trade secrets or commercial
                                              Potential Commercial Applications                       would constitute a clearly unwarranted                property such as patentable material,
                                                • To study the molecular mechanisms                   invasion of personal privacy.                         and personal information concerning
                                              of bone formation and                                    Name of Committee: National Institute of             individuals associated with the grant
                                              osteodifferentiation.                                   Neurological Disorders and Stroke Special             applications, the disclosure of which


                                         VerDate Sep<11>2014   18:45 Aug 03, 2015   Jkt 235001   PO 00000   Frm 00078   Fmt 4703   Sfmt 4703   E:\FR\FM\04AUN1.SGM   04AUN1



Document Created: 2015-12-18 14:51:25
Document Modified: 2015-12-18 14:51:25
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
DatesAugust 11, 2015.
FR Citation80 FR 46311 

2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR